Can transcranial direct current stimulation help attention in Lewy body dementia?
- Conditions
- Health Condition 1: null- Dementia with Lewy bodies and Parkinsons Disease with Dementia
- Registration Number
- CTRI/2015/05/005751
- Lead Sponsor
- Institute of Neurosciences Kolkata
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 65
Participants are required to
Have been stable on anti-cholinesterase, anti-psychotic, memantine and/or anti-parkinsonian medication for at least one month prior to participation.
Be able to provide written, informed consent
Be free from concurrent major psychiatric illness (e.g. major depression).
Be free from any severe physical illness or co-morbidities which might limit their ability to fully participate in the study, or influence the effects of tDCS.
Participants will be unable to take part if any of the following apply:
If they have skin allergies or sensitivities to electrode gels, or any significant dermatological / scalp disease.
A history of excess alcohol intake.
A history of moderate-to-severe visual impairment secondary to glaucoma, cataract, or macular degeneration.
If they have metallic implants in the head/neck area or electronic implants of any kind (including pacemakers).
If they have a history of other neurological illness including, but not limited to stroke, intracerebral pathology and epilepsy.
If they are currently taking psychotropic or other medications which may significantly interfere with cognitive testing and tDCS efficacy (including high dose antipsychotics, dopamine agoinsts, sedative antidepressants, benzodiazepines except when low dose and used as hypnotics or treatment for REM-sleep behaviour disorder and centrally acting anticholinergic drugs).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Four computerised attentional tasks: Simple reaction time; Choice reaction time; Digit Vigilance; Modified Attentional Network Task. <br/ ><br>Timepoint: Time 1 and Time 2 (between 24 hours and one week after Time 1) <br/ ><br>
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable